Skip to main content
Clinical Trials/NCT00710944
NCT00710944
Completed
N/A

An Open, Prospective, Controlled Study in the Maxilla to Evaluate Clinical Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants in Single Tooth Replacement Using an Immediate Loading Protocol in Extraction Sockets and Healed Ridges.

Dentsply Sirona Implants and Consumables4 sites in 4 countries132 target enrollmentApril 2005

Overview

Phase
N/A
Intervention
Not specified
Conditions
Jaw, Edentulous, Partially
Sponsor
Dentsply Sirona Implants and Consumables
Enrollment
132
Locations
4
Primary Endpoint
Implant Survival
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to evaluate survival for ASTRA TECH Implant System, OsseoSpeed™ implants following immediate loading in extraction sockets versus immediate loading in healed ridges. Patients in need of single standing implants replacing teeth in the maxilla within zone 15-25 will be included and followed for 5 years. Primary objective is implant survival rate at 12 months.

Registry
clinicaltrials.gov
Start Date
April 2005
End Date
November 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Dentsply Sirona Implants and Consumables
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Provision of written informed consent
  • 18 years of age and over
  • A minimum of 20 stable intra occlusal contacts after planned restoration
  • In need of single standing implants replacing missing / extracted / avulsed teeth in the maxilla within zone 15 to 25

Exclusion Criteria

  • Untreated rampant caries and uncontrolled periodontal disease
  • Use of smoking tobacco at time of inclusion
  • History of pre-surgical bone augmentation, within 4 months, in the planned implant area
  • History of extraction without augmentation, within 3 months in the planned implant area
  • Absence of opposing dentition
  • Absence of adjacent (mesial and/or distal) natural tooth
  • Uncontrolled diabetes
  • Known pregnancy at time of inclusion
  • Present alcohol or drug abuse
  • Any systemic or local disease or condition that would compromise post-operative healing and/or osseointegration

Outcomes

Primary Outcomes

Implant Survival

Time Frame: 12 months after implant placement

An implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.

Study Sites (4)

Loading locations...

Similar Trials